Building a House of Brands, not a House of Cards
VANCOUVER, BC, March 31, 2022 /CNW/ – YourWay Cannabis Brands Inc. (CSE: YOUR) (OTC: YOURF) (FSE: HOB) (the “Company” or “YourWay“), a multi-state and consumer-centric House of Brands committed to redefining the way consumers and cannabis brands interact, today announced Executive Chairman Jakob Ripshtein will participate in an exclusive interview at the upcoming Benzinga Cannabis Capital Conference, the world’s biggest and most successful cannabis investing and finance event.
The conference will take place on April 20 and April 21, 2022, at the Fontainebleau Miami Beach hotel in Miami, Florida. Mr. Ripshtein will speak on the conference’s final day with moderator Scott Greiper, founder and President of Viridian Capital Advisors. Mr. Ripshtein will be discussing YourWay’s strategic vision to build a comprehensive family of brands designed to create a sense of belonging for every cannabis consumer.
“At YourWay, we are building a House of Brands, not a House of Cards,” said Ripshtein. “The cannabis industry might be new, but building brands isn’t. Rooted in a history of CPG brand building, YourWay is taking a proven approach to creating a differentiated portfolio of brands empowering consumers with value and variety, brands with reach and access, and retailers with increased demand and traffic. Utilizing decades of branding expertise and an integral understanding of the consumer experience, YourWay builds brands that align to distinct consumer segments, need states and occasions.”
Mr. Ripshtein will be speaking at 3:50 p.m. ET on April 21, 2022. Interested parties can register to attend the conference here.
Members of the YourWay management team will also be holding one-on-one investor and discovery meetings throughout the two-day conference.
About YourWay Cannabis Brands
YourWay Cannabis Brands is a publicly-traded, multi-state and consumer-centric House of Brands committed to redefining the way consumers and cannabis brands interact with sales and operations in Arizona and California. Through building their own brands, partnering with others, and supporting our retail partner’s house brand strategy, they are dedicated to expanding their reach, remolding the cannabis industry and ultimately redefining the way consumers and cannabis brands interact.
YourWay aims to connect with the cannabis consumer on a deeper level, utilizing decades of brand-building expertise and an integral understanding of the customer experience to create an intuitive suite of branded products that closely align with consumer need states. The YourWay portfolio is an all-encompassing house of brands designed to create a sense of belonging for every cannabis consumer regardless of their relationship with the plant. Please visit www.yourwaycannabis.com or follow on Twitter at @yourwaycannabis for the latest news and information about YourWay and its brands.
About The Benzinga Cannabis Capital Conference
The premier gathering of cannabis entrepreneurs and investors in North America is returning to Miami.
The next iteration of the famed Benzinga Cannabis Capital Conference will gather industry insiders and investors from around the world once again on April 20 and 21 in Miami. Attendees can expect two full days of keynotes, panel discussions, fireside chats, networking, company presentations, celebrity appearances, and more.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This news release includes certain “forward-looking information” as defined under applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: Mr. Ripshtein’s speaking engagement at the Benzinga Cannabis Capital Conference; the Company’s strategy of building a comprehensive family of brands; the Company’s approach to creating a differentiated portfolio of brands; the implementation of the Company’s ‘House of Brands’ cannabis consumer packaged goods strategy; investor and discovery meetings with the Company’s management team; and expectations for other economic, business, and/or competitive factors. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information.
Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in consumer demand and preferences; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; compliance with extensive government regulation; public opinion and perception of the cannabis industry; the impact of COVID-19; and the risk factors set out in the Company’s annual information form dated August 28, 2020, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.
The Company, through several of its subsidiaries, is indirectly involved in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States. Local state laws where the Company operates permit such activities however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable United States federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward nonenforcement against individuals and businesses that comply with recreational and medicinal cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under United States federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information, which speak only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE YourWay Cannabis Brands
For further information: Glen Shear, Head of Investor Relations, [email protected], YourWay Cannabis Brands; For media inquiries, please contact: [email protected]; For investor inquiries, please contact: [email protected]